News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Lytix Biopharma to Take Lead Cancer Compound into Clinic


3/31/2008 11:46:53 AM

TROMS0, Norway--(BUSINESS WIRE)--The Scandinavian-based drug development company Lytix Biopharma announced its intention to take its lead anti-cancer molecule LTX-315 through to clinical trials. This decision follows the selection of Lytix’s first lead antimicrobial compound towards end of 2007.

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES